Federal Circuit Reverses PTAB’s Conclusion that Claims Challenged in Reexamination Would Have Been Obvious

Sep 13, 2016

Reading Time : 1 min

The 330 Patent is directed to a composition for deicing road surfaces using a natural product known as “desugared sugar beet molasses” (DSBM). DSBM was previously considered a waste product and it costs less than half the cost of regular molasses. Univar, a licensee of the 330 Patent, filed three requests for reexamination of the 330 Patent. An examiner found a substantial new question of patentability, merged the reexaminations and ultimately found the challenged claims unpatentable in light of three prior art references. The PTAB agreed. On appeal, Natural argued that the examiner and the PTAB never established a prima facie case of obviousness because they failed to address the differences between the references and the challenged claims. Natural further argued that the PTAB failed to consider objective evidence of nonobviousness.

The Federal Circuit agreed with Natural and reiterated that, in a patent reexamination, it is the examiner’s burden to demonstrate a prima facie case of obviousness. The first reference taught making molasses in the traditional sugared form. It did not teach making DSBM. The PTAB ignored the fact that the second reference was directed to a substantially different problem and failed to explain why the teachings would be reasonably pertinent to deicing road surfaces. Similarly, the PTAB failed to address the differences between the third reference and the invention taught in the 330 Patent. Finally, the PTAB erred in finding no nexus between the objective evidence of record and the claimed invention; the prior art taught using molasses in general, not using DSBM specifically (which the prior art considered a waste product). Accordingly, the Federal Circuit reversed the PTAB’s judgment that the challenged claims were unpatentable as obvious.

In re: Natural Alternatives, LLC, No. 2015-1911 (Fed. Cir. Aug. 31, 2016).

Share This Insight

Previous Entries

IP Newsflash

February 20, 2026

The Federal Circuit recently addressed whether the PTO must conduct notice‑and‑comment rulemaking before issuing instructions that guide how the Board should exercise discretion at the institution stage of IPRs. The court held that no such rulemaking is required. Instructions to the Board regarding its use of the Director’s delegated discretionary authority not to institute review are merely general statements of policy exempt from notice-and-comment rulemaking.  

...

Read More

IP Newsflash

February 18, 2026

The District Court for the District of Delaware recently invalidated claims directed to a panoramic objective lens for lack of enablement, holding the claims impermissibly recited a single element in means‑plus‑function form. Under § 112, ¶ 6, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function….” By its plain terms, the statute permits means‑plus‑function claiming only in the context of a “combination.” In other words, a claim may not consist solely of a single means‑plus‑function element. Claims drafted as a single means are invalid for lack of enablement as a matter of law.

...

Read More

IP Newsflash

February 13, 2026

In an ANDA litigation, the District of Delaware recently denied the defendants’ motion to compel the production of correspondence between the plaintiffs’ testifying expert and a third-party analyst who had performed experiments and provided data used by the testifying expert. The court found that the scope of material sought by the motion was overbroad and disproportionate to the needs of the case.

...

Read More

IP Newsflash

February 12, 2026

In an ANDA litigation, the District of Delaware recently denied the plaintiffs’ motion to strike portions of the defendants’ expert reports and related deposition testimony. Although the defendants’ invalidity contentions did not state the specific theories of invalidity upon which the expert opined, the court found that none of the Pennypack factors supported excluding that expert testimony.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.